Skip to main content
OpenTrials
Completed

NCT Number: NCT01301079

Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia

The aim of this study was to determine if the addition of ketamine reduces remifentanil-induced hyperalgesia, improves its analgesic effect, inhibits IL(interleukin)-6 and IL-8 (inflammatory cytokines), and stimulates IL-10 (an anti-inflammatory cytokine).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Hyperalgesia Inflammatory Response Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Somatosensory Disorders

Age range

18 year–78 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Federal University of São Paulo

São Paulo, Brazil

About this study

Opioids are very effective in pain relief, but they might lower pain threshold, making the patient more sensitive to a pain stimulus, a condition known as hyperalgesia [Angst; Clarck, 2006]. Opioid-induced hyperalgesia (OIH) is usually defined as a reduction in nociceptive thresholds in the peripheral field of the sensitized fibers [Koppert et al., 2003], and it is associated with increased pain and higher demand for postoperative analgesia [Guignard et al., 2000]. This phenomenon adversely impacts pain control, and has been suggested to occur in the peri-operative context, especially associated with the use of remifentanil, a short-acting opioid [Guignard et al., 2000].

Several mechanisms have been proposed to explain the hyperalgesia phenomenon, but the most important seems to be the activation of N-methyl-D-aspartate (NMDA) receptors [Célèrier et al., 2000]. Ketamine is a NMDA receptor antagonist that has been shown to reduce postoperative pain and the need for postoperative anesthetics and analgesics. Therefore, it is proposed that ketamine could prevent hyperalgesia, resulting in more effective and long-lasting postsurgical analgesia [Célèrier et al. 2000].

The results of studies of low dose of ketamine in the prevention of remifentanil-induced hyperalgesia are controversial. Joly et al. [2005] demonstrated a reduction in the consumption of opioids and in hyperalgesia assessed with monofilaments. However, Engelhardt et al [2008] showed no differences in pain scores or in postoperative opioid consumption.

In addition, some authors observed higher levels of proinflammatory cytokines, associated with increased pain in mice receiving chronic opioid (morphine) infusion [Johnston et al., 2004; Liang et al., 2008]. Also, administration of proinflammatory cytokine inhibitors reduced phosphorylation of NMDA receptors [Zhang et al., 2008]. However, no study has examined the relationship between the use of remifentanil, the most frequently implicated opioid in OIH [Guignard et al., 2000], ketamine (drug capable of inhibiting NMDA-receptors and cytokines) [Dale et al., 2012], and the inflammatory response.

The aim of this study was to determine if the addition of ketamine reduces remifentanil-induced hyperalgesia, improves its analgesic effect, inhibits IL-6 and IL-8 (inflammatory cytokines), and stimulates IL-10 (an anti-inflammatory cytokine) in patients submitted to laparoscopic cholecystectomy, a procedure with an usually neglected potential for postoperative pain and that has been poorly investigated in association with OIH.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years old
  • both sexes
  • ASA physical status I or II
  • undergoing laparoscopic cholecystectomy

Exclusion criteria

  • chronic users of analgesics or had used opioids within 12 h of surgery
  • history of drug or alcohol abuse or psychiatric disorder
  • contraindications to self-administration of opioids (ie, unable to understand the patient-controlled analgesia [PCA] device)
  • contraindication for the use of ketamine, such as a psychiatric disorder, acute cardiovascular disorder, or unstable hypertension

Treatment and study plan

ketamine

Drug

Patients in group ketamine was administrated ketamine (5mcg/kg/min) during the surgery.

Saline

Drug

Patients in group N (placebo) was administrated saline during surgery.

Primary outcomes

  1. Pain 30 Minutes

    Time frame: 30 minutes

    The scale measure pain after 30 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  2. Pain 60 Minutes

    Time frame: 60 minutes

    The scale measure pain after 60 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  3. Pain 90 Minutes

    Time frame: 90 minutes

    The scale measure pain after 90 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  4. Pain 120 Minutes

    Time frame: 120 minutes

    The scale measure pain after 120 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  5. Pain 150 Minutes

    Time frame: 150 minutes

    The scale measure pain after 150 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  6. Pain 180 Minutes

    Time frame: 180 minutes

    The scale measure pain after 180 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  7. Pain 210 Minutes

    Time frame: 210 minutes

    The scale measure pain after 210 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  8. Pain 240 Minutes

    Time frame: 240 minutes

    The scale measure pain after 240 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  9. Pain 6 Hours

    Time frame: 6 hours

    The scale measure pain after 6 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  10. Pain 12 Hours

    Time frame: 12 hours

    The scale measure pain after 12 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  11. Pain 18 Hours

    Time frame: 18 hours

    The scale measure pain after 18 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

  12. Pain 24 Hours

    Time frame: 24 hours

    The scale measure pain after 24 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.

Secondary outcomes

  1. Time to First Morphine Supplementation

    Time frame: 24 hours

  2. Morphine Consumption Within 24 h

    Time frame: 24 hours

  3. Hyperalgesia in the Preoperative Period as Measured With Monofilaments in Thenar Eminence

    Time frame: Before the procedure (Baseline)

    The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in thenar eminence in the preoperative period. The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.

  4. Hyperalgesia in the Postoperative Period as Measured With Monofilaments in Thenar Eminence

    Time frame: 24 hours after procedure

    The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in thenar eminence in the postoperative period (24 hours after procedure). The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.

  5. Hyperalgesia in the Preoperative Period as Measured With Monofilaments in the Periumbilical Region

    Time frame: Before the procedure (Baseline)

    The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in the periumbilical region in the preoperative period. The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.

  6. Hyperalgesia in the Postoperative Period as Measured With Monofilaments in the Periumbilical Region

    Time frame: 24h after the procedure

    The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in the periumbilical region in the postoperative period (24h after the procedure). The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.

  7. Hyperalgesia in the Preoperative Period as Measured With Algometer in Thenar Eminence

    Time frame: Baseline (before the procedure)

    The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.

  8. Hyperalgesia in the Postoperative Period as Measured With Algometer in Thenar Eminence

    Time frame: 24 h after the procedure

    The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.

  9. Hyperalgesia in the Preoperative Period as Measured With Algometer in the Periumbilical Region

    Time frame: Baseline (before the surgery)

    The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.

  10. Hyperalgesia in the Postoperative Period as Measured With Algometer in the Periumbilical Region

    Time frame: 24 h after the procedure

    The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.

  11. Extension of Hyperalgesia

    Time frame: 24 hours after the procedure

    The 300-g filament was used 24 hours after the operation to induce a stimulus and delineate the extent of hyperalgesia from the periumbilical region. The stimulus was started outside the periumbilical region, where no pain sensation was reported, and continued every 0.5 cm until the 4 points of the periumbilical scar were reached (top, right side, left side, and bottom). The first point where the patient complained of pain was marked. If no pain sensation was reported, the stimulus was terminated 0.5 cm from the incision. The distance of each point from the surgical incision was measured, and the sum of the distances of the points was determined.

  12. Allodynia as Detected With a Soft Brush in the Periumbilical Region Before the Procedure

    Time frame: Before the procedure (Baseline)

    The evaluations using the soft brush were performed 2-3 cm from the incision in the periumbilical region (where the large trocar was placed) before the procedure

  13. Allodynia as Detected With a Soft Brush in the Periumbilical Region 24 h After the Procedure

    Time frame: 24 h after the procedure

    The evaluations using the soft brush were performed 2-3 cm from the incision in the periumbilical region (where the large trocar was placed) 24 h after the procedure

  14. Allodynia as Detected With a Soft Brush in the Thenar Eminence Before the Procedure

    Time frame: Before the procedure (Baseline)

    The evaluations using the soft brush were performed in the thenar eminence of the nondominant hand before the procedure

  15. Allodynia as Detected With a Soft Brush in the Thenar Eminence 24 h After the Procedure

    Time frame: 24 h after the procedure

    The evaluations using the soft brush were performed in the thenar eminence of the non dominant hand 24 h after the procedure

  16. Serum Level of Interleukin (IL)-6 Before the Procedure

    Time frame: Baseline (Before the procedure)

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  17. Serum Level of Interleukin (IL)-6 5 h After the Procedure

    Time frame: 5 h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  18. Serum Level of Interleukin (IL)-6 24 h After the Procedure

    Time frame: 24 h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  19. Serum Level of Interleukin (IL)-8 Before the Procedure

    Time frame: Baseline (Before the procedure)

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  20. Serum Level of Interleukin (IL)-8 5 h After the Procedure

    Time frame: 5 h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  21. Serum Level of Interleukin (IL)-8 24 h After the Procedure

    Time frame: 24 h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  22. Serum Level of Interleukin (IL)-10 Before the Procedure

    Time frame: Baseline (Before the procedure)

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  23. Serum Level of Interleukin (IL)-10 5h After the Procedure

    Time frame: 5h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-10 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

  24. Serum Level of Interleukin (IL)-10 24 h After the Procedure

    Time frame: 24 h after the procedure

    Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.

Sponsors and collaborators

Lead sponsor

Federal University of São Paulo

Other

Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Registry information

Official study title

Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia Using Filaments, an Algometer, and Interleukins: a Double-blind, Randomized Study

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Feb 23, 2011
Registry last updated
Nov 10, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.